Immunotherapy can be more effective in NSCLC patients who … – News-Medical.net
News-Medical.net |
Immunotherapy can be more effective in NSCLC patients who …
News-Medical.net A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with … |
